Exact Mass: 606.3278

Fulvestrant

C32H47F5O3S (606.3166)

Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in post-menopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both by down-regulating and by degrading the estrogen receptor. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BA - Anti-estrogens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2116 - Selective Estrogen Receptor Down Regulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents

(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)

C33H50O10 (606.3404)

(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide) is a natural human metabolite of (23S)-23,25-dihdroxy-24-oxovitamine D3 generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.

13-Methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

C32H47F5O3S (606.3166)

N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine

C34H46N4O6 (606.3417)

PA(8:0/5-iso PGF2VI)

C29H51O11P (606.3169)

PA(8:0/5-iso PGF2VI) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/5-iso PGF2VI), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(5-iso PGF2VI/8:0)

C29H51O11P (606.3169)

PA(5-iso PGF2VI/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(5-iso PGF2VI/8:0), in particular, consists of one chain of one 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Scortechinone G

C35H42O9 (606.2829)

Caseobliquin B

C35H42O9 (606.2829)

[7-acetyloxy-4,6-di(butanoyloxy)-8-hydroxy-3a,5a,9-trimethyl-1-propan-2-yl-1,2,3,4,5,6,7,8,10a,10b-decahydrocyclohepta[e]inden-2-yl] butanoate

C34H54O9 (606.3768)

Caucasicoside A

C33H50O10 (606.3404)

Taxuspine C

C35H42O9 (606.2829)

5-alpha-4,5-Dihydro-scillirosidin 3-O-alpha-L-quinovopyranoside

C32H46O11 (606.304)

Plantagiolide E

C32H46O11 (606.304)

Tautomycetin

C33H50O10 (606.3404)

Scupontin B

C32H46O11 (606.304)

Methyl phaeophorbide

C36H38N4O5 (606.2842)

Methyl pheophorbide a is practically insoluble (in water) and an extremely strong acidic compound (based on its pKa). Methyl pheophorbide a can be found in japanese persimmon, which makes methyl pheophorbide a a potential biomarker for the consumption of this food product.

Taxinine

C35H42O9 (606.2829)

Fusapyrone

C34H54O9 (606.3768)

1-deacetylkhivorin

C35H42O9 (606.2829)

Pheophorbide a methyl ester

C36H38N4O5 (606.2842)

[(1R,3R,5S,7S,8S,9R,10R)-7,9,10-triacetyloxy-8,12,15,15-tetramethyl-4-methylidene-13-oxo-5-tricyclo[9.3.1.0^{3,8]pentadec-11-enyl] (E)-3-phenylprop-2-enoate

C35H42O9 (606.2829)

Agave-Saponin A

C34H54O9 (606.3768)

physaloside A

C29H50O13 (606.3251)

2beta-Acetoxy-6beta-cinnamoyloxyisozuelanin

C35H42O9 (606.2829)

Euphorbia factor Ti7

C36H46O8 (606.3193)

schizonellin B

C30H54O12 (606.3615)

Dibenzoylgagaimol

C35H42O9 (606.2829)

C36H46O8

C36H46O8 (606.3193)

C30H54O12

C30H54O12 (606.3615)

glaucacetalin B

C33H50O10 (606.3404)

Arenastatin A|cryptophycin 24|cryptophycin-24

C34H42N2O8 (606.2941)

C33H50O10

C33H50O10 (606.3404)

gagunin F

C34H54O9 (606.3768)

3beta-(beta-glucopyranosyloxyuronic acid)-16-hydroxy-5alpha,14beta-cholest-16-ene-15,23-dione|pandaroside D

C33H50O10 (606.3404)

gagunin E

C34H54O9 (606.3768)

2alpha,3beta-dihydroxy-spirost-5,25(27)-diene-1beta-yl O-beta-D-galactopyranoside|atropuroside D

C33H50O10 (606.3404)

anthogorgiene M

C44H46O2 (606.3498)

7alpha-acetoxy-21R?,23R?-epoxy-1alpha,24S?,25-trihydroxy-21alpha-ethoxy-4,4,8-trimethyl-cholesta-14-en-3-one|brujavanone N

C34H54O9 (606.3768)

cochinchinoid C

C36H46O8 (606.3193)

(22E,24S)-3beta,25-dihydroxy-15alpha-O-beta-D-glucopyranosyl-ergosta-7,22-dien-6-one|fomentarol D

C34H54O9 (606.3768)

brialalepolide C

C32H46O11 (606.304)

A natural product found in Briareum species.

26-O-beta-D-glucopyranosyl-(25R)-furostan-4-ene-22alpha,26-diol-3,12-dione|Terrestrinone A1

C33H50O10 (606.3404)

12-O-(6-O-acetyl-beta-D-glucopyranosyl-(1?2)-beta-D-glucopyranosyl)-campherenane-2-endo,12-diol

C29H50O13 (606.3251)

walsucochinoid R

C36H46O8 (606.3193)

Elansolid B1

C37H50O7 (606.3556)

iriomoteolide-13a

C33H50O10 (606.3404)

C32H46O11

C32H46O11 (606.304)

(1S,4R,5S,6R,7R,8R,9S,10S)-6-acetoxy-1,9-dibenzoyloxy-8-butyryloxydihydro-beta-agarofuran

C35H42O9 (606.2829)

1alpha,7alpha-diacetoxy-17alpha-20S-21,24-epoxy-apotirucall-14-ene-3alpha,23R,24S,25-tetraol

C34H54O9 (606.3768)

5alpha-cinnamoyloxy-2alpha,10beta,13alpha-triacetoxy-2(3->2)abeo-taxa-4(20),11-dien-9-one

C35H42O9 (606.2829)

Roxaticin

C34H54O9 (606.3768)

1beta,24beta-dihydroxy-spirost-5,25(27)-dien-3alpha-yl O-beta-D-glucopyranoside|tupistroside B

C33H50O10 (606.3404)

atrata-phloroglucinol B

C36H46O8 (606.3193)

O1-Deacetyl-O7-detigloyl-O7-benzoylnimbolinin B

C35H42O9 (606.2829)

1alpha,2alpha-di-(alpha-methyl)-butanoyloxy-4beta-hydroxy-9beta-(beta-)furoyloxy-15-acetoxy-beta-dihydroagarofuran|1??,2??-Di-(a-methyl)-butanoyl-4??-hydroxy-9??-(??-)furoyloxy-15-acetoxy-??-dihydroagarofuran

C32H46O11 (606.304)

phorbol 20-trityl|phorbol 20-tritylether|phorbol-20-trityl ether|Phorbol-20-tritylaether

C39H42O6 (606.2981)

20-hydroxyecdysone 2,3,22-triacetate|20-hydroxyecdysone-2,3,22-triacetate|Ecdysteron-2,3,22-triacetat|Ecdysteron-triacetat-(2,3,22)|ecdysterone 2,3,22-triacetate|ecdysterone 2beta,3beta,22R-triacetate|ecdysterone triacetate

C33H50O10 (606.3404)

ajugamacrin C

C32H46O11 (606.304)

Phe Ala Glu Lys Ile

C29H46N6O8 (606.3377)

Phe Gln Lys Lys Gly

C28H46N8O7 (606.3489)

Tyr Val Lys Ala Leu

C30H50N6O7 (606.3741)

Arg Tyr Ile Arg

C27H46N10O6 (606.3602)

Thr Lys Met Val Glu

C25H46N6O9S (606.3047)

Ile Arg Tyr Arg

C27H46N10O6 (606.3602)

NCI60_003881

C36H38N4O5 (606.2842)

Methyl phaeophorbide is a natural product found in Saussurea medusa with data available.

Taxinin

C35H42O9 (606.2829)

Taxinine is a natural product found in Taxus wallichiana, Taxus baccata, and other organisms with data available.

Fulvestrant

C32H47F5O3S (606.3166)

L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BA - Anti-estrogens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2116 - Selective Estrogen Receptor Down Regulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents

2-Deacetoxy taxinine B

C35H42O9 (606.2829)

C33H50O10_(1beta,3beta,9xi,11alpha,14xi)-1,3,11-Trihydroxyfurosta-5,20(22),25-trien-27-yl beta-D-glucopyranoside

C33H50O10 (606.3404)

C32H46O11_Carda-4,20(22)-dienolide, 6-(acetyloxy)-3-[(6-deoxy-3-O-methyl-beta-D-galactopyranosyl)oxy]-8,14-dihydroxy-, (3beta,8xi,9xi)

C32H46O11 (606.304)

3-[(2R,3S,4R,6R)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxy-6-[(4E,6E,9Z)-3-hydroxy-8-(hydroxymethyl)-2,6,10,12-tetramethyloctadeca-4,6,9-trien-2-yl]pyran-2-one

C34H54O9 (606.3768)

3-O-p-hydroxybenzoyl ceanothic acid

C37H50O7 (606.3556)

(3R,6R)-6-((3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-3,7-diacetoxy-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptane-1,3-diyl diacetate

C34H54O9 (606.3768)

(3R,6R)-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7-diacetoxy-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptane-1,3-diyl diacetate

C34H54O9 (606.3768)

Glu Phe Arg Arg

C26H42N10O7 (606.3238)

Glu Arg Phe Arg

C26H42N10O7 (606.3238)

Glu Arg Arg Phe

C26H42N10O7 (606.3238)

Phe Glu Arg Arg

C26H42N10O7 (606.3238)

Phe Phe Phe Phe

C36H38N4O5 (606.2842)

Phe Arg Glu Arg

C26H42N10O7 (606.3238)

Phe Arg Arg Glu

C26H42N10O7 (606.3238)

Phe Arg Val Trp

C31H42N8O5 (606.3278)

Phe Arg Trp Val

C31H42N8O5 (606.3278)

Phe Val Arg Trp

C31H42N8O5 (606.3278)

Phe Val Trp Arg

C31H42N8O5 (606.3278)

Phe Trp Arg Val

C31H42N8O5 (606.3278)

Phe Trp Val Arg

C31H42N8O5 (606.3278)

His His Lys Trp

C29H38N10O5 (606.3026)

His His Trp Lys

C29H38N10O5 (606.3026)

His Lys His Trp

C29H38N10O5 (606.3026)

His Lys Trp His

C29H38N10O5 (606.3026)

His Trp His Lys

C29H38N10O5 (606.3026)

His Trp Lys His

C29H38N10O5 (606.3026)

Ile Arg Arg Tyr

C27H46N10O6 (606.3602)

Ile Tyr Arg Arg

C27H46N10O6 (606.3602)

Lys His His Trp

C29H38N10O5 (606.3026)

Lys His Trp His

C29H38N10O5 (606.3026)

Lys Trp His His

C29H38N10O5 (606.3026)

Leu Arg Arg Tyr

C27H46N10O6 (606.3602)

Leu Arg Tyr Arg

C27H46N10O6 (606.3602)

Leu Tyr Arg Arg

C27H46N10O6 (606.3602)

Arg Glu Phe Arg

C26H42N10O7 (606.3238)

Arg Glu Arg Phe

C26H42N10O7 (606.3238)

Arg Phe Glu Arg

C26H42N10O7 (606.3238)

Arg Phe Arg Glu

C26H42N10O7 (606.3238)

Arg Phe Val Trp

C31H42N8O5 (606.3278)

Arg Phe Trp Val

C31H42N8O5 (606.3278)

Arg Ile Arg Tyr

C27H46N10O6 (606.3602)

Arg Ile Tyr Arg

C27H46N10O6 (606.3602)

Arg Leu Arg Tyr

C27H46N10O6 (606.3602)

Arg Leu Tyr Arg

C27H46N10O6 (606.3602)

Arg Arg Glu Phe

C26H42N10O7 (606.3238)

Arg Arg Phe Glu

C26H42N10O7 (606.3238)

Arg Arg Ile Tyr

C27H46N10O6 (606.3602)

Arg Arg Leu Tyr

C27H46N10O6 (606.3602)

Arg Arg Tyr Ile

C27H46N10O6 (606.3602)

Arg Arg Tyr Leu

C27H46N10O6 (606.3602)

Arg Val Phe Trp

C31H42N8O5 (606.3278)

Arg Val Trp Phe

C31H42N8O5 (606.3278)

Arg Trp Phe Val

C31H42N8O5 (606.3278)

Arg Trp Val Phe

C31H42N8O5 (606.3278)

Arg Tyr Leu Arg

C27H46N10O6 (606.3602)

Arg Tyr Arg Ile

C27H46N10O6 (606.3602)

Arg Tyr Arg Leu

C27H46N10O6 (606.3602)

Val Phe Arg Trp

C31H42N8O5 (606.3278)

Val Phe Trp Arg

C31H42N8O5 (606.3278)

Val Arg Phe Trp

C31H42N8O5 (606.3278)

Val Arg Trp Phe

C31H42N8O5 (606.3278)

Val Trp Phe Arg

C31H42N8O5 (606.3278)

Val Trp Arg Phe

C31H42N8O5 (606.3278)

Trp Phe Arg Val

C31H42N8O5 (606.3278)

Trp Phe Val Arg

C31H42N8O5 (606.3278)

Trp His His Lys

C29H38N10O5 (606.3026)

Trp His Lys His

C29H38N10O5 (606.3026)

Trp Lys His His

C29H38N10O5 (606.3026)

Trp Arg Phe Val

C31H42N8O5 (606.3278)

Trp Arg Val Phe

C31H42N8O5 (606.3278)

Trp Val Phe Arg

C31H42N8O5 (606.3278)

Trp Val Arg Phe

C31H42N8O5 (606.3278)

Tyr Ile Arg Arg

C27H46N10O6 (606.3602)

Tyr Leu Arg Arg

C27H46N10O6 (606.3602)

Tyr Arg Ile Arg

C27H46N10O6 (606.3602)

Tyr Arg Leu Arg

C27H46N10O6 (606.3602)

Tyr Arg Arg Ile

C27H46N10O6 (606.3602)

Tyr Arg Arg Leu

C27H46N10O6 (606.3602)

FAEKI

C29H46N6O8 (606.3377)

FQKKG

C28H46N8O7 (606.3489)

YVGRL

C28H46N8O7 (606.3489)

ESLMK

C25H46N6O9S (606.3047)

TKMVE

C25H46N6O9S (606.3047)

Trandolapril glucuronide

C30H42N2O11 (606.2788)

1,25-Dihydroxy-20S-21-(3-hydroxy-3-methylbutyl)-23-yne-26,27-hexafluorovitamin D3

C32H44F6O4 (606.3144)

(5Z,7E)-(3S,23S)-24-oxo-9,10-seco-5,7,10(19)-cholestatriene-3,23,25-triol 23-D-glucuronide

C33H50O10 (606.3404)

(23S)-23,25-dihydroxy-24-oxovitamin D3 23-(beta-glucuronide)

C33H50O10 (606.3404)

OA-PA

C30H55O10P (606.3533)

OHODiA-PA

C29H51O11P (606.3169)

Cucurbitacin C3

C34H54O9 (606.3768)

Fomentarol D

C34H54O9 (606.3768)

ST 27:3;O4;GlcA

C33H50O10 (606.3404)

Pandaroside D

C33H50O10 (606.3404)

(1s,2s)-(+)-[1,2-cyclohexanediamino-n n-bis(3,5-di-t-butylsalicylidene)]aluminum (iii) chloride

C36H52AlClN2O2 (606.3533)

Butyltin tris(2-ethylhexanoate)

C28H54O6Sn (606.2942)

(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N-bis-(3,5-di-tert-butylsalicylidene)]aluminum(III)chloride

C36H52AlClN2O2 (606.3533)

(R)-(-)-1-[(S)-2-Dicyclohexylphosphino)ferrocenyl]ethyldicyclohexylphosphine

C36H56FeP2 (606.3206)

(S,S)-N,N-bis-(3,5-Di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride

C36H52AlClN2O2 (606.3533)

(s,s)-1-dicyclohexylphosphino-2-[1-(dicyclohexylphosphino)ethyl]ferrocene

C36H56FeP2 (606.3206)

17-methoxy-10,12-dimethyl-18-(3,4,5-trimethoxy-benzoyloxy)-yohimbane-16-carboxylic acid methyl ester

C34H42N2O8 (606.2941)

PHOOA-PE

C29H53NO10P- (606.3407)

N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine

C34H46N4O6 (606.3417)

PA(8:0/5-iso PGF2VI)

C29H51O11P (606.3169)

PA(5-iso PGF2VI/8:0)

C29H51O11P (606.3169)

4-[2-(2-Benzyloxycarbonylamino-3-methyl-butyrylamino)-3-phenyl-propionylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid, ethyl ester

C33H42N4O7 (606.3053)

Fusahexin

C30H50N6O7 (606.3741)

Dilazep hydrochloride

C31H46N2O10+2 (606.3152)

Gemini-0072

C32H44F6O4 (606.3144)

Gemini0097

C32H44F6O4 (606.3144)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3029)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3029)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3029)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3029)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3029)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3029)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3029)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3029)

(3R,6R)-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7-diacetoxy-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptane-1,3-diyl diacetate

C34H54O9 (606.3768)

(7R,8S,9S,13S,14R,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

C32H47F5O3S (606.3166)

(2S)-2-[[(2S)-2-[[4-ethyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]oxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid

C26H46N4O10S (606.2934)

N-[5-[4-(3,6-diaminoacridin-10-ium-10-yl)butanoylamino]pentyl]-5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanamide

C32H44N7O3S+ (606.3226)

CID 54710122

C34H54O9 (606.3768)

2-Deacetoxytaxinine B

C35H42O9 (606.2829)

(7R,8R,9R,13R,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

C32H47F5O3S (606.3166)

Mgdg O-22:6_3:0

C34H54O9 (606.3768)

[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C33H50O10 (606.3404)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C30H55O10P (606.3533)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C30H55O10P (606.3533)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C30H55O10P (606.3533)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C30H55O10P (606.3533)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C30H55O10P (606.3533)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C30H55O10P (606.3533)

(3R,6R)-6-((3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-3,7-diacetoxy-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptane-1,3-diyl diacetate

C34H54O9 (606.3768)

[1-phosphonooxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C33H51O8P (606.3321)

[1-phosphonooxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C33H51O8P (606.3321)

13-Methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

C32H47F5O3S (606.3166)

(1S,4S,8S,9S,11R,13R,14R,16R)-7,9,13-trimethyl-6-[3-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]but-3-enyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,18-diene-11,14,16-triol

C33H50O10 (606.3404)

MGDG O-25:6

C34H54O9 (606.3768)

DGMG 13:3

C28H46O14 (606.2887)

MGMG 25:6

C34H54O9 (606.3768)

SQMG 20:3

C29H50O11S (606.3074)

DGGA 21:0;O

C30H54O12 (606.3615)

DGGA 23:6

C32H46O11 (606.304)

MGGA 24:6

C33H50O10 (606.3404)

PA O-16:0/11:3;O3

C30H55O10P (606.3533)

PA O-20:0/7:3;O3

C30H55O10P (606.3533)

PA O-27:3;O3

C30H55O10P (606.3533)

PA P-20:0/7:2;O3

C30H55O10P (606.3533)

PA 14:0/12:3;O3

C29H51O11P (606.3169)

PA 14:1/12:2;O3

C29H51O11P (606.3169)

PA 18:0/8:3;O3

C29H51O11P (606.3169)

PA 18:1/8:2;O3

C29H51O11P (606.3169)

PA 18:1/9:1;O2

C30H55O10P (606.3533)

PA 20:0/7:2;O2

C30H55O10P (606.3533)

PA 22:1/5:1;O2

C30H55O10P (606.3533)

PA 22:5/7:3;O

C32H47O9P (606.2958)

PA 29:8;O

C32H47O9P (606.2958)

LPGP 19:0

C25H52O12P2 (606.2934)

LPGP O-20:0

C26H56O11P2 (606.3298)

PG O-16:0/8:3;O

C30H55O10P (606.3533)

PG O-23:4;O2

C29H51O11P (606.3169)

PG O-24:3;O

C30H55O10P (606.3533)

PG P-16:0/7:3;O2

C29H51O11P (606.3169)

PG P-16:1/7:2;O2

C29H51O11P (606.3169)

PG P-16:1/8:1;O

C30H55O10P (606.3533)

PG P-18:0/6:2;O

C30H55O10P (606.3533)

PG P-18:1/5:2;O2

C29H51O11P (606.3169)

PG P-20:1/4:1;O

C30H55O10P (606.3533)

PG 14:1/8:3;O2

C28H47O12P (606.2805)

PG 16:0/7:3;O

C29H51O11P (606.3169)

PG 18:2/5:1;O

C29H51O11P (606.3169)

PG 18:3/4:1;O2

C28H47O12P (606.2805)

PG 22:4;O2

C28H47O12P (606.2805)

PG 23:3;O

C29H51O11P (606.3169)

PG 20:1/4:1

C30H55O10P (606.3533)

PG 2:0_22:2

C30H55O10P (606.3533)

PG 20:2/4:0

C30H55O10P (606.3533)

PG 22:2/2:0

C30H55O10P (606.3533)

PG 24:2

C30H55O10P (606.3533)

LPEth 29:7

C34H55O7P (606.3685)

LPM 30:7

C34H55O7P (606.3685)

PEth 28:7

C33H51O8P (606.3321)

PM 28:8;O

C32H47O9P (606.2958)

PM 29:7

C33H51O8P (606.3321)

ST 22:0;O8;GlcA

C28H46O14 (606.2887)

ST 26:4;O5;GlcA

C32H46O11 (606.304)

ST 28:2;O3;GlcA

C34H54O9 (606.3768)

ST 23:0;O8;Hex

C29H50O13 (606.3251)

ST 26:5;O6;Hex

C32H46O11 (606.304)

ST 27:4;O5;Hex

C33H50O10 (606.3404)

ST 29:1;O8;S

C29H50O11S (606.3074)

(1r,8r,10r)-2,9,10-tris(acetyloxy)-8,12,15,15-tetramethyl-4-methylidene-13-oxotricyclo[9.3.1.0³,⁸]pentadec-11-en-5-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2829)

(2r,3r,4s,5r,6r)-2-{[(2r,3r,4r,5s)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-[(3-methylbut-2-enoyl)oxy]oxan-3-yl dodecanoate

C29H50O13 (606.3251)

(1r,3r,5s,7s,8s,9r,10r)-7,9,10-tris(acetyloxy)-8,12,15,15-tetramethyl-4-methylidene-13-oxotricyclo[9.3.1.0³,⁸]pentadec-11-en-5-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2829)

(1r,3r,5r,6as,7r,8r,10s,10as)-1,3,5-tris(acetyloxy)-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2829)

2,10,13-tris(acetyloxy)-8,12,15,15-tetramethyl-9-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-3,11-dien-5-yl 3-phenylprop-2-enoate

C35H42O9 (606.2829)

2-[8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-[(2-methylpropanoyl)oxy]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl 2-methylpropanoate

C32H46O11 (606.304)

(2r,3r)-2-[(1s,3as,5ar,7r,8s,9ar,9br,11ar)-7,8-bis(acetyloxy)-3a-hydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-dihydroxy-6-methylheptan-3-yl acetate

C33H50O10 (606.3404)

(1s,2s,3ar,5r,10r,11s,13r,13ar)-3a,11,13-tris(acetyloxy)-2,5,8,8-tetramethyl-12-methylidene-10-(2-methylpropoxy)-4,9-dioxo-1h,2h,3h,5h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl acetate

C32H46O11 (606.304)

(2s,3as,6r,7as)-n-(1-carbamimidoylpyrrolidin-2-yl)-1-[(2r)-2-{[(2r)-3-(3-chloro-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C29H43ClN6O6 (606.2932)

(1s,3s,5s,6ar,7s,8s,10r,10ar)-1,3,5-tris(acetyloxy)-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2829)

(1r,3s,3ar,5as,7s,9ar,9br,11ar)-7-hydroxy-1-[(2r,3e,5s)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C34H54O9 (606.3768)

methyl 16-ethenyl-11-ethyl-22-(3-methoxy-3-oxopropyl)-12,17,21,26-tetramethyl-4-oxo-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1(23),2(6),5(26),7,9,11,13,15,17,19-decaene-3-carboxylate

C36H38N4O5 (606.2842)

2-(hydroxymethyl)-6-{7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-15',16'-dioloxy}oxane-3,4,5-triol

C33H50O10 (606.3404)

17-(acetyloxy)-8-(furan-3-yl)-4,19-dihydroxy-1,9,11,16-tetramethyl-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-12-yl benzoate

C35H42O9 (606.2829)

1-deacetylnimbolinin a

C35H42O9 (606.2829)

{"Ingredient_id": "HBIN002467","Ingredient_name": "1-deacetylnimbolinin a","Alias": "NA","Ingredient_formula": "C35H42O9","Ingredient_Smile": "CC1=C2C(CC1C3=COC=C3)OC(CC4C2(C(C5C6C4(C(CC(C6(CO5)C)OC(=O)C)O)C)OC(=O)C7=CC=CC=C7)C)O","Ingredient_weight": "606.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4754","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "100945036","DrugBank_id": "NA"}

1- o -deacetylnimbolinin a

C35H42O9 (606.2829)

{"Ingredient_id": "HBIN002895","Ingredient_name": "1- o -deacetylnimbolinin a","Alias": "NA","Ingredient_formula": "C35H42O9","Ingredient_Smile": "NA","Ingredient_weight": "606.711","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9732","PubChem_id": "NA","DrugBank_id": "NA"}

20-hydroxyecdysone-2,3,20,22-diacetonide

C33H50O10 (606.3404)

{"Ingredient_id": "HBIN003412","Ingredient_name": "20-hydroxyecdysone-2,3,20,22-diacetonide","Alias": "NA","Ingredient_formula": "C33H50O10","Ingredient_Smile": "CC(=O)OC1CC2C(=O)C=C3C(C2(CC1OC(=O)C)C)CCC4(C3(CCC4C(C)(C(CCC(C)(C)O)OC(=O)C)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42189","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

methyl 3-(acetyloxy)-2,13,20,21-tetrahydroxy-25-methoxy-5,8,22-trimethyl-11-methylidene-24-oxahexacyclo[15.5.3.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]pentacosane-14-carboxylate

C33H50O10 (606.3404)

methyl (3r,21s,22s)-16-ethenyl-11-ethyl-4-hydroxy-22-(3-methoxy-3-oxopropyl)-12,17,21,26-tetramethyl-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaene-3-carboxylate

C36H38N4O5 (606.2842)

(2r,3s,4s,5r,6r)-3-(acetyloxy)-6-[(acetyloxy)methyl]-5-hydroxy-2-[(2r,3s)-2,3,4-trihydroxybutoxy]oxan-4-yl hexadecanoate

C30H54O12 (606.3615)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10as,10br)-7-(acetyloxy)-4,6-bis(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C34H54O9 (606.3768)

methyl (3r,21s,22s)-16-ethenyl-11-ethyl-22-(3-methoxy-3-oxopropyl)-12,17,21,26-tetramethyl-4-oxo-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1(23),2(6),5(26),8,10(25),11,13,15,17,19-decaene-3-carboxylate

C36H38N4O5 (606.2842)

2-[7,8-bis(acetyloxy)-3a-hydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-dihydroxy-6-methylheptan-3-yl acetate

C33H50O10 (606.3404)

(1r,2s,3e,5r,8r,10r,13s)-2,10,13-tris(acetyloxy)-8,12,15,15-tetramethyl-9-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-3,11-dien-5-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2829)

(3s,10r,13z,16s)-9,12-dihydroxy-10-[(4-methoxyphenyl)methyl]-3-(2-methylpropyl)-16-[(1s)-1-[(2r,3r)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H42N2O8 (606.2941)

3a,11,13-tris(acetyloxy)-2,5,8,8-tetramethyl-12-methylidene-10-(2-methylpropoxy)-4,9-dioxo-1h,2h,3h,5h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl acetate

C32H46O11 (606.304)

3-[(2r,3r,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(3s,4e,6e,8s)-8-[(1z,4r)-2,4-dimethyldec-1-en-1-yl]-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-2-hydroxypyran-4-one

C34H54O9 (606.3768)

12-(acetyloxy)-7-(benzoyloxy)-8-(butanoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate

C35H42O9 (606.2829)

(1r,3ar,3bs,5r,5as,7s,9as,9br,11ar)-3a,3b-dihydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C32H46O11 (606.304)

2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-[(3-methylbut-2-enoyl)oxy]oxan-3-yl dodecanoate

C29H50O13 (606.3251)

(1s,2s,4s,8s,9s,11r,12s,13r,14r,16r)-7,9,13-trimethyl-6-[3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosa-6,18-diene-11,14,16-triol

C33H50O10 (606.3404)

3-[(2s,3s,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(4e,6e)-8-[(1z)-2,4-dimethyldec-1-en-1-yl]-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-4-hydroxypyran-2-one

C34H54O9 (606.3768)

4-(5-{2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl}-8-(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy)-4-oxobutan-2-yl 3-(acetyloxy)butanoate

C32H46O11 (606.304)

3-(acetyloxy)-2-(hydroxymethyl)-5-[(2-methylpropanoyl)oxy]-6-(2,3,4-trihydroxybutoxy)oxan-4-yl tetradecanoate

C30H54O12 (606.3615)

(2r,3r,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,7's,8'r,9's,12's,13'r,14's,15's,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-15',16'-dioloxy]oxane-3,4,5-triol

C33H50O10 (606.3404)

4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl octadec-11-enoate

C30H54O12 (606.3615)

7,9-dihydroxy-15-{1-hydroxy-4-[hydroxy(4-hydroxyphenyl)methyl]-1,3,3,6-tetramethyl-3a,4,5,7a-tetrahydro-2h-inden-5-yl}-4,8-dimethylpentadeca-2,4,10,12,14-pentaenoic acid

C37H50O7 (606.3556)

4,8,15,19,26,30-hexahydroxy-1,12,23-trioxa-4,9,15,20,26,31-hexaazacyclotritriaconta-8,19,30-triene-5,16,27-trione

C24H42N6O12 (606.2861)

(3s,10r,13e,16s)-9,12-dihydroxy-10-[(4-methoxyphenyl)methyl]-3-(2-methylpropyl)-16-[(1s)-1-[(2r,3r)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H42N2O8 (606.2941)

methyl (2e)-4-[(1r,2r,7s,16s,18s)-11-hydroxy-16-methoxy-6,6,7,20,20-pentamethyl-10-(3-methylbut-2-en-1-yl)-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4,9,11,14-tetraen-18-yl]-2-methylbut-2-enoate

C35H42O9 (606.2829)

methyl (3s,21s,22r)-16-ethenyl-11-ethyl-22-(3-methoxy-3-oxopropyl)-12,17,21,26-tetramethyl-4-oxo-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1(23),2(6),5(26),8,10(25),11,13,15,17,19-decaene-3-carboxylate

C36H38N4O5 (606.2842)

2-({3-[(1ar,2s,7r,7ar,7bs)-1,1,7,7a-tetramethyl-1ah,2h,4h,5h,6h,7h,7bh-cyclopropa[a]naphthalen-2-yl]-5-butanoyl-2,4,6-trihydroxyphenyl}methyl)-6-acetyl-3,5-dihydroxy-4,4-dimethylcyclohexa-2,5-dien-1-one

C36H46O8 (606.3193)

(2s)-4-[(1r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,6ar)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-8-(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy]-4-oxobutan-2-yl (3s)-3-(acetyloxy)butanoate

C32H46O11 (606.304)

(1s)-2-[(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-[(2-methylpropanoyl)oxy]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl 2-methylpropanoate

C32H46O11 (606.304)

17-ethyl-4,8-dihydroxy-3,7,11,13-tetramethyl-6,15-dioxononadeca-16,18-dien-2-yl 3-hydroxy-3-(4-methyl-2,5-dioxofuran-3-yl)propanoate

C33H50O10 (606.3404)

(1s,2s,3ar,5r,10r,11s,13r,13ar)-3a,11,13-tris(acetyloxy)-10-[(2s)-butan-2-yloxy]-2,5,8,8-tetramethyl-12-methylidene-4,9-dioxo-1h,2h,3h,5h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl acetate

C32H46O11 (606.304)

(3z,5z,7z,9z,11z,13s,14r,16r,18r,22s,24r,26r,27z,29s,30s)-14,16,18,20,22,24,26-heptahydroxy-30-isopropyl-13,29-dimethyl-1-oxacyclotriaconta-3,5,7,9,11,27-hexaen-2-one

C34H54O9 (606.3768)

(2r,3r,4r,7s,10r,11r,14s)-2,3,10-tris(acetyloxy)-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadecan-7-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2829)

10,14,15-trimethoxy-4,20-dimethyl-28-oxa-4,20-diazaheptacyclo[27.2.2.1⁷,¹¹.1¹³,¹⁷.1²³,²⁷.0³,⁸.0²¹,³⁵]hexatriaconta-1(31),7,9,11(36),13,15,17(35),23,25,27(34),29,32-dodecaen-26-ol

C38H42N2O5 (606.3094)

(2r,3r,4s,5s,6r)-3-(acetyloxy)-2-(hydroxymethyl)-5-[(2-methylpropanoyl)oxy]-6-[(2r,3s)-2,3,4-trihydroxybutoxy]oxan-4-yl tetradecanoate

C30H54O12 (606.3615)

(16e)-17-ethyl-4,8-dihydroxy-3,7,11,13-tetramethyl-6,15-dioxononadeca-16,18-dien-2-yl (3r)-3-hydroxy-3-(4-methyl-2,5-dioxofuran-3-yl)propanoate

C33H50O10 (606.3404)

(1r,2r,3r,4r,7s,10r,11r,14s)-2,3,10-tris(acetyloxy)-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadecan-7-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2829)

methyl 16-ethenyl-11-ethyl-4-hydroxy-22-(3-methoxy-3-oxopropyl)-12,17,21,26-tetramethyl-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaene-3-carboxylate

C36H38N4O5 (606.2842)

(2s,3s,4s,7r,8s,11r,13r,16e)-17-ethyl-4,8-dihydroxy-3,7,11,13-tetramethyl-6,15-dioxononadeca-16,18-dien-2-yl (3r)-3-hydroxy-3-(4-methyl-2,5-dioxofuran-3-yl)propanoate

C33H50O10 (606.3404)

7-hydroxy-1-(6-hydroxy-5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C34H54O9 (606.3768)

(3s,10r,13e,16s)-9,12-dihydroxy-10-[(4-methoxyphenyl)methyl]-3-(2-methylpropyl)-16-[(1r)-1-[(2r,3r)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H42N2O8 (606.2941)

n-[(2r,3e)-4-[(9r,10r,14ar,16ar,17s,19s,20ar,20br)-17-(c-hydroxycarbonimidoyloxy)-19-methoxy-3,10,13,20b-tetramethyl-7-oxo-9h,10h,14ah,16ah,17h,18h,19h,20h,20ah-naphtho[2,1-h]oxacyclohexadecan-9-yl]pent-3-en-2-yl]ethanimidic acid

C36H50N2O6 (606.3669)

10-(acetyloxy)-16-[1-(4,5-dihydroxy-4,5-dimethyl-6-oxooxan-2-yl)ethyl]-5-hydroxy-11,15-dimethyl-3,8-dioxahexacyclo[10.7.0.0²,⁴.0⁵,¹¹.0⁷,⁹.0¹⁵,¹⁹]nonadecan-14-yl acetate

C32H46O11 (606.304)

(9e,11e,15z)-1,19-dihydroxy-5-[(1e,3e)-6-hydroxy-3,5-dimethylhepta-1,3-dien-1-yl]-6,16,20-trimethoxy-2,10,14-trimethyl-4,21-dioxabicyclo[15.3.1]henicosa-9,11,15-trien-3-one

C34H54O9 (606.3768)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10ar,10bs)-8-(acetyloxy)-4,6-bis(butanoyloxy)-7-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C34H54O9 (606.3768)

(1s,2r,4s,7s,8s,11r,12s,13s,15r,17s,19r)-19-(acetyloxy)-7-(furan-3-yl)-13-hydroxy-1,8,12,16,16-pentamethyl-5-oxo-3,6-dioxapentacyclo[9.8.0.0²,⁴.0²,⁸.0¹²,¹⁷]nonadecan-15-yl benzoate

C35H42O9 (606.2829)

(1r,2r,3r,4r,7s,9r,10r,11r,14s)-2,3,10-tris(acetyloxy)-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadecan-7-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2829)

2-[(3-{1,1,7,7a-tetramethyl-1ah,2h,4h,5h,6h,7h,7bh-cyclopropa[a]naphthalen-2-yl}-5-butanoyl-2,4,6-trihydroxyphenyl)methyl]-6-acetyl-3,5-dihydroxy-4,4-dimethylcyclohexa-2,5-dien-1-one

C36H46O8 (606.3193)

3-[(2r,3s,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(4e,6e)-8-[(1z)-2,4-dimethyldec-1-en-1-yl]-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-4-hydroxypyran-2-one

C34H54O9 (606.3768)

(1s,2r,3r,4r,7s,9r,10r,11r,14s)-2,3,10-tris(acetyloxy)-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadecan-7-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2829)

methyl (1s,2s,3s,4r,5r,8r,13s,14s,17s,18r,20r,21r,22r,25s)-3-(acetyloxy)-2,13,20,21-tetrahydroxy-25-methoxy-5,8,22-trimethyl-11-methylidene-24-oxahexacyclo[15.5.3.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]pentacosane-14-carboxylate

C33H50O10 (606.3404)

(1r,2r,4r,6s,8r,11r,12s,13r,16r,17r,19s,20r)-17-(acetyloxy)-8-(furan-3-yl)-4,19-dihydroxy-1,9,11,16-tetramethyl-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-12-yl benzoate

C35H42O9 (606.2829)

3-(acetyloxy)-6-[(acetyloxy)methyl]-5-hydroxy-2-(2,3,4-trihydroxybutoxy)oxan-4-yl hexadecanoate

C30H54O12 (606.3615)

(2s,3s,4s,5r,6r)-6-{[(3ar,3br,5as,7s,9as,9bs,11as)-2-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methyl-4-oxoheptan-2-yl]-3-oxo-3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C33H50O10 (606.3404)

2,3,10-tris(acetyloxy)-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadecan-7-yl 3-phenylprop-2-enoate

C35H42O9 (606.2829)

1,3,5-tris(acetyloxy)-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 3-phenylprop-2-enoate

C35H42O9 (606.2829)

3a,3b-dihydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C32H46O11 (606.304)

(2e)-5-[(1s,2r,4ar,8ar)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-({[(2s,3s,4r,5s)-3,4,5-tris(acetyloxy)oxan-2-yl]oxy}methyl)pent-2-en-1-yl acetate

C33H50O10 (606.3404)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10ar,10bs)-7-(acetyloxy)-4,6-bis(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C34H54O9 (606.3768)

(1s,2s,3ar,5s,10r,11s,13r,13ar)-3a,11,13-tris(acetyloxy)-2,5,8,8-tetramethyl-12-methylidene-10-(2-methylpropoxy)-4,9-dioxo-1h,2h,3h,5h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl acetate

C32H46O11 (606.304)

7,9,13-trimethyl-6-[3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosa-6,18-diene-11,14,16-triol

C33H50O10 (606.3404)

(1r,2r,3r,4r,7s,9r,10r,11r,14r)-2,3,10-tris(acetyloxy)-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadecan-7-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2829)

6-[2,5-dihydroxy-4-(4-hydroxycyclohexyl)-3,6-dioxocyclohexa-1,4-dien-1-yl]-12,14-dihydroxy-11-oxo-10,13-bis(sec-butyl)-2,9-dioxa-1,12-diazatricyclo[8.4.0.0³,⁸]tetradec-13-en-1-ium-1-olate

C30H42N2O11 (606.2788)

3,4,5-trihydroxy-6-{[2-hydroxy-9a,11a-dimethyl-1-(6-methyl-4-oxoheptan-2-yl)-3-oxo-3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-2-carboxylic acid

C33H50O10 (606.3404)

3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[8-(2,4-dimethyldec-1-en-1-yl)-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-4-hydroxypyran-2-one

C34H54O9 (606.3768)

3a,11,13-tris(acetyloxy)-2,5,8,8-tetramethyl-12-methylidene-4,9-dioxo-10-(sec-butoxy)-1h,2h,3h,5h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl acetate

C32H46O11 (606.304)

3-[(2s,3r,4s,6s)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(4e,6e)-8-[(1z)-2,4-dimethyldec-1-en-1-yl]-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-4-hydroxypyran-2-one

C34H54O9 (606.3768)

(2s,3r,4s,5r)-2-{[(1r,9s,12r,14s,17r,22s)-2-hydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17-tetramethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}oxane-3,4,5-triol

C34H54O9 (606.3768)

1,3,5-tris(acetyloxy)-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 3-phenylprop-2-enoate

C35H42O9 (606.2829)

1,19-dihydroxy-5-(6-hydroxy-3,5-dimethylhepta-1,3-dien-1-yl)-6,16,20-trimethoxy-2,10,14-trimethyl-4,21-dioxabicyclo[15.3.1]henicosa-9,11,15-trien-3-one

C34H54O9 (606.3768)

(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl (11z)-octadec-11-enoate

C30H54O12 (606.3615)

(2s)-4-[(1r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,6as)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-8-(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy]-4-oxobutan-2-yl (3s)-3-(acetyloxy)butanoate

C32H46O11 (606.304)

(1s,2s,4s,8s,9s,11r,12s,13r,14r,16r)-7,9,13-trimethyl-6-[3-({[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosa-6,18-diene-11,14,16-triol

C33H50O10 (606.3404)

5-(1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)-3-({[3,4,5-tris(acetyloxy)oxan-2-yl]oxy}methyl)pent-2-en-1-yl acetate

C33H50O10 (606.3404)

(1'r,2s,2'r,3'r,5's,8'r,9'r,10'r)-2',10'-bis(acetyloxy)-8',12',15',15'-tetramethyl-13'-oxo-5'-[(triethylsilyl)oxy]spiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-9'-yl acetate

C32H50O9Si (606.3224)

(1s,2r,5s,6s,7s,8r,9r,12r)-12-(acetyloxy)-5-(benzoyloxy)-8-(butanoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C35H42O9 (606.2829)

(16e)-17-ethyl-4,8-dihydroxy-3,7,11,13-tetramethyl-6,15-dioxononadeca-16,18-dien-2-yl 3-hydroxy-3-(4-methyl-2,5-dioxofuran-3-yl)propanoate

C33H50O10 (606.3404)

(1s,2s,4s,5r,7s,9s,10r,11s,12s,14s,15r,16r,19s)-10-(acetyloxy)-16-[(1s)-1-[(2r,4r,5r)-4,5-dihydroxy-4,5-dimethyl-6-oxooxan-2-yl]ethyl]-5-hydroxy-11,15-dimethyl-3,8-dioxahexacyclo[10.7.0.0²,⁴.0⁵,¹¹.0⁷,⁹.0¹⁵,¹⁹]nonadecan-14-yl acetate

C32H46O11 (606.304)

(1s,2r,3s,4s,5r,8s,9s,11r,12z,14s,17r)-2,9-bis(acetyloxy)-4,5-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadeca-6,12-dien-11-yl octanoate

C32H46O11 (606.304)

9,12-dihydroxy-10-[(4-methoxyphenyl)methyl]-3-(2-methylpropyl)-16-[1-(3-phenyloxiran-2-yl)ethyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H42N2O8 (606.2941)

(1'r,2r,2'r,3'r,5's,8'r,9'r,10'r)-2',10'-bis(acetyloxy)-8',12',15',15'-tetramethyl-13'-oxo-5'-[(triethylsilyl)oxy]spiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-9'-yl acetate

C32H50O9Si (606.3224)

methyl 4-[11-hydroxy-16-methoxy-6,6,7,20,20-pentamethyl-10-(3-methylbut-2-en-1-yl)-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4,9,11,14-tetraen-18-yl]-2-methylbut-2-enoate

C35H42O9 (606.2829)

(2s)-2-[(1-hydroxy-2-{[(1s,2r)-2-hydroxy-1-{[(1s,2s)-2-hydroxy-1-{[(2s)-4-methyl-1-[(2r)-oxiran-2-yl]-1-oxopentan-2-yl]-c-hydroxycarbonimidoyl}propyl]-c-hydroxycarbonimidoyl}propyl]-c-hydroxycarbonimidoyl}-2-methylethylidene)amino]-3-phenylpropanoic acid

C29H42N4O10 (606.2901)

(1r,3ar,3bs,5r,5as,7s,9as,9br,11ar)-3a,3b-dihydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-7-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C32H46O11 (606.304)